StonvexLoading…
StonvexStonvexStonvexCore line items from CRH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $37.45B | $35.57B | $34.95B | $32.72B |
Operating Income | $5.44B | $4.92B | $4.19B | $3.81B |
Net Income | $3.75B | $3.49B | $3.18B | $3.86B |
EPS (Diluted) | $5.51 | $5.02 | $4.33 | $5.11 |
Total Assets | $58.33B | $50.61B | $47.47B | $45.32B |
Total Liabilities | $32.85B | $27.76B | $25.85B | $22.28B |
Cash & Equivalents | $4.10B | $3.72B | $6.34B | $5.94B |
Free Cash Flow OCF − CapEx | $2.91B | $2.41B | $3.20B | $2.28B |
Shares Outstanding | 706.95M | 718.65M | 734.52M | 752.14M |